BDAZ, thanks for the reply and the link.  That was an excellent post but it would seem that, from the MD&A, BTI is going to have to raise money for clinical trials through a financing rather than through a cash flowing deal.  Good thing that thus far management has kept dilution to a bare minimum.  Still no reply from BTI regarding my cost and timeline questions re clinical trials.